PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsIodixanol
Iodixanol
Iodixanol, Visipaque (iodixanol) is an unknown pharmaceutical. Iodixanol was first approved as Visipaque 270 on 1996-03-22.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Iodixanol, Visipaque (discontinued: Visipaque)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Iodixanol
Tradename
Company
Number
Date
Products
VISIPAQUE 270GE HealthcareN-020351 RX1996-03-22
1 products, RLD, RS
VISIPAQUE 320GE HealthcareN-020351 RX1996-03-22
1 products, RLD, RS
VISIPAQUE 320GE HealthcareN-020808 RX1997-08-29
1 products
Show 1 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
bl-c kitunapproved drug other2024-12-31
iodixanolANDA2023-07-21
visipaqueNew Drug Application2023-05-08
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
V: Various drug classes in atc
— V08: Contrast media
— V08A: X-ray contrast media, iodinated
— V08AB: Watersoluble, nephrotropic, low osmolar x-ray contrast media
— V08AB09: Iodixanol
HCPCS
No data
Clinical
Clinical Trials
67 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Coronary artery diseaseD003324—I25.1——2349
Renal insufficiencyD051437—N19———3—3
Healthy volunteers/patients———11—1—2
Coronary diseaseD003327—————112
Myocardial ischemiaD017202EFO_1001375I20-I25———112
Diabetes mellitusD003920EFO_0000400E08-E13———2—2
HypothyroidismD007037EFO_0004705E03.9———1—1
Chronic renal insufficiencyD051436—N18———1—1
Kidney diseasesD007674EFO_0003086N08———1—1
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Myocardial infarctionD009203EFO_0000612I21————11
St elevation myocardial infarctionD000072657——————11
InfarctionD007238EFO_0009463—————11
Chest painD002637—R07.9————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameIodixanol
INNiodixanol
Description
Iodixanol is a dimeric, non-ionic, water-soluble, radiographic contrast agent, used particularly in coronary angiography. It has a role as a radioopaque medium.
Classification
Small molecule
Drug classiodine-containing contrast media
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CC(=O)N(CC(O)CN(C(C)=O)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I
Identifiers
PDB—
CAS-ID92339-11-2
RxCUI—
ChEMBL IDCHEMBL1200507
ChEBI ID31705
PubChem CID3724
DrugBankDB01249
UNII IDHW8W27HTXX (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 9,769 documents
View more details
Safety
Black-box Warning
Black-box warning for: Bl-c kit, Iodixanol, Visipaque
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
3,010 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use